Ypsomed Holding AG (YPHDF)
OTCMKTS · Delayed Price · Currency is USD
535.75
0.00 (0.00%)
At close: Jul 21, 2025
Kronos Bio Market Cap
Ypsomed Holding AG has a market cap or net worth of $6.59 billion as of August 1, 2025. Its market cap has increased by 1.94% in one year.
Market Cap
6.59B
Enterprise Value
6.88B
Revenue
847.18M
Ranking
n/a
PE Ratio
66.61
Stock Price
$535.75
Market Cap Chart
Since September 22, 2004, Ypsomed Holding AG's market cap has increased from 646.56M to 6.59B, an increase of 919.81%. That is a compound annual growth rate of 11.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 6.59B | 33.79% |
| Dec 30, 2024 | 4.93B | 0.35% |
| Dec 29, 2023 | 4.91B | 97.10% |
| Dec 30, 2022 | 2.49B | -3.34% |
| Dec 30, 2021 | 2.58B | 21.96% |
| Dec 30, 2020 | 2.11B | 23.96% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 396.28M |
| Northwest Biotherapeutics | 376.73M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 366.82M |